What is the role of antimicrobial peptides (AMP) in acne vulgaris?

Experimental Dermatology

Volumn 22, Issue 6, 2013, Pages 386-391

  Harder, Jürgen ^a   Tsuruta, Daisuke ^b   Murakami, Masamoto ^c   Kurokawa, Ichiro ^d,e  

^a UNIVERSITY OF KIEL   (Germany)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Meiwa Hospital   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Acne vulgaris; Antimicrobial peptides; Cathelicidin; Defensin

Indexed keywords

ADRENOMEDULLIN; ANTIBIOTIC AGENT; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE; CYTOKINE; GRANULYSIN; HUMAN NEUTROPHIL PEPTIDE 1 3; ISOTRETINOIN; LAURIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 7; S 100A 7; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACNE; ACNE VULGARIS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DERMATITIS; GENE EXPRESSION; KERATINOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROPIONIBACTERIUM ACNES; UPREGULATION;

ACNE VULGARIS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; DEFENSINS; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MODELS, BIOLOGICAL; PROPIONIBACTERIUM ACNES;

EID: 84878367861     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12159     Document Type: Article

References (97)

1. Goulden V, McGeown C H, Cunliffe W J. Br J Dermatol 1999: 141: 297-300.
2. Leyden J J, Del Rosso J Q, Webster G F. Dermatol Clin 2009: 27: 1-15.
3. Yahya H. Int J Dermatol 2009: 48: 498-505.
4. Shamban A T, Narurkar V A. Dermatol Clin 2009: 27: 459-471, vi.
5. Kurokawa I, Danby F W, Ju Q et al. Exp Dermatol 2009: 18: 821-832.
6. Parish L C, Witkowski J A. Am J Med Sci 1967: 254: 769-776.
7. Piaserico S, Fortina A B, Cavallini F et al. Acta Derm Venereol 2009: 89: 312-313.
8. Essah P A, Wickham E P 3rd, Nunley J R et al. Clin Dermatol 2006: 24: 289-298.
9. Gloor M, Wasik B, Becker A et al. Dermatology 2002: 205: 260-264.
10. Hoffler U. Zentralbl Bakteriol Orig A 1979: 245: 123-129.
11. Sugisaki H, Yamanaka K, Kakeda M et al. J Dermatol Sci 2009: 55: 47-52.
12. Williams H C, Dellavalle R P, Garner S. Lancet 2012: 379: 361-372.
13. Gamble R, Dunn J, Dawson A et al. Am J Clin Dermatol 2012: 13: 141-152.
14. Zuliani T, Khammari A, Chaussy H et al. Exp Dermatol 2011: 20: 850-853.
15. Eady E A, Cove J H, Holland K T et al. Br J Dermatol 1989: 121: 51-57.
16. Bhambri S, Del Rosso J Q, Bhambri A. J Drugs Dermatol 2009: 8: 615-618.
17. Schittek B, Paulmann M, Senyurek I et al. Infect Disord Drug Targets 2008: 8: 135-143.
18. Reddy K V, Yedery R D, Aranha C. Int J Antimicrob Agents 2004: 24: 536-547.
19. Gallo R L, Murakami M, Ohtake T et al. J Allergy Clin Immunol 2002: 110: 823-831.
20. Harder J, Gläser R, Schröder J M. J Endotoxin Res 2007: 13: 317-338.
21. Gläser R, Harder J, Lange H et al. Nat Immunol 2005: 6: 57-64.
22. Simanski M, Dressel S, Gläser R et al. J Invest Dermatol 2010: 130: 2836-2838.
23. Köten B, Simanski M, Gläser R et al. PLoS One 2009: 4: e6424.
24. Harder J, Schröder J M. J Biol Chem 2002: 277: 46779-46784.
25. Abtin A, Eckhart L, Gläser R et al. J Invest Dermatol 2010: 130: 2423-2430.
26. Schittek B, Hipfel R, Sauer B et al. Nat Immunol 2001: 2: 1133-1137.
27. Harder J, Dressel S, Wittersheim M et al. J Invest Dermatol 2010: 130: 1355-1364.
28. Harder J, Gläser R, Schröder J M. Endocr Metab Immune Disord Drug Targets 2007: 7: 75-82.
29. Oppenheim J J, Yang D. Curr Opin Immunol 2005: 17: 359-365.
30. Koczulla R, von Degenfeld G, Kupatt C et al. J Clin Invest 2003: 111: 1665-1672.
31. De Y, Chen Q, Schmidt A P et al. J Exp Med 2000: 192: 1069-1074.
32. Yamasaki K, Di Nardo A, Bardan A et al. Nat Med 2007: 13: 975-980.
33. Henseler T, Christophers E. J Am Acad Dermatol 1995: 32: 982-986.
34. Jansen P A, Rodijk-Olthuis D, Hollox E J et al. PLoS One 2009: 4: e4725.
35. Hollox E J, Huffmeier U, Zeeuwen P L et al. Nat Genet 2008: 40: 23-25.
36. Brown K L, Poon G F, Birkenhead D et al. J Immunol 2011: 186: 5497-5505.
37. Dombrowski Y, Peric M, Koglin S et al. Sci Transl Med 2011: 3: 82ra38.
38. Marta Guarna M, Coulson R, Rubinchik E. FEMS Microbiol Lett 2006: 257: 1-6.
39. Scott A, Weldon S, Buchanan P J et al. PLoS One 2011: 6: e26525.
40. Scott M G, Davidson D J, Gold M R et al. J Immunol 2002: 169: 3883-3891.
41. Semple F, MacPherson H, Webb S et al. Eur J Immunol 2011: 41: 3291-3300.
42. Semple F, Webb S, Li H N et al. Eur J Immunol 2010: 40: 1073-1078.
43. Chronnell C M, Ghali L R, Ali R S et al. J Invest Dermatol 2001: 117: 1120-1125.
44. Philpott M P. Mol Immunol 2003: 40: 457-462.
45. Trivedi N R, Gilliland K L, Zhao W et al. J Invest Dermatol 2006: 126: 1071-1079.
46. Lee S E, Kim J M, Jeong S K et al. Arch Dermatol Res 2010: 302: 745-756.
47. Nagy I, Pivarcsi A, Kis K et al. Microbes Infect 2006: 8: 2195-2205.
48. Jugeau S, Tenaud I, Knol A C et al. Br J Dermatol 2005: 153: 1105-1113.
49. Nakatsuji T, Kao M C, Zhang L et al. J Invest Dermatol 2010: 130: 985-994.
50. Graham G M, Farrar M D, Cruse-Sawyer J E et al. Br J Dermatol 2004: 150: 421-428.
51. Lyte P, Sur R, Nigam A et al. Exp Dermatol 2009: 18: 1070-1072.
52. Schaller M, Loewenstein M, Borelli C et al. Br J Dermatol 2005: 153: 66-71.
53. Lee D Y, Yamasaki K, Rudsil J et al. J Invest Dermatol 2008: 128: 1863-1866.
54. Reithmayer K, Meyer K C, Kleditzsch P et al. Br J Dermatol 2009: 161: 78-89.
55. Dressel S, Harder J, Cordes J et al. Exp Dermatol 2010: 19: 628-632.
56. Schlapbach C, Yawalkar N, Hunger R E. J Am Acad Dermatol 2009: 61: 58-65.
57. Ganceviciene R, Fimmel S, Glass E et al. Dermatology 2006: 213: 270-272.
58. Zouboulis C C, Voorhees J J, Orfanos C E et al. Arch Dermatol Res 1996: 288: 664-669.
59. Krensky A M, Clayberger C. Tissue Antigens 2009: 73: 193-198.
60. McInturff J E, Wang S J, Machleidt T et al. J Invest Dermatol 2005: 125: 256-263.
61. Niyonsaba F, Iwabuchi K, Matsuda H et al. Int Immunol 2002: 14: 421-426.
62. Niyonsaba F, Ushio H, Nagaoka I et al. J Immunol 2005: 175: 1776-1784.
63. Niyonsaba F, Ushio H, Nakano N et al. J Invest Dermatol 2007: 127: 594-604.
64. Rohrl J, Yang D, Oppenheim J J et al. J Immunol 2010: 184: 6688-6694.
65. Soruri A, Grigat J, Forssmann U et al. Eur J Immunol 2007: 37: 2474-2486.
66. Yang D, Chertov O, Bykovskaia S N et al. Science 1999: 286: 525-528.
67. Harder J, Meyer-Hoffert U, Wehkamp K et al. J Invest Dermatol 2004: 123: 522-529.
68. Schmidt N, Gans E H. J Clin Aesthet Dermatol 2011: 4: 22-29.
69. Dispenza M C, Wolpert E B, Gilliland K L et al. J Invest Dermatol 2012: 132: 2198-2205.
70. Jarrousse V, Castex-Rizzi N, Khammari A et al. Eur J Dermatol 2007: 17: 492-496.
71. Shibata M, Katsuyama M, Onodera T et al. J Invest Dermatol 2009: 129: 375-382.
72. Adisen E, Yuksek J, Erdem O et al. J Eur Acad Dermatol Venereol 2010: 24: 32-37.
73. Befus A D, Mowat C, Gilchrist M et al. J Immunol 1999: 163: 947-953.
74. Presicce P, Giannelli S, Taddeo A et al. J Leukoc Biol 2009: 86: 941-948.
75. Yang D, Biragyn A, Kwak L W et al. Trends Immunol 2002: 23: 291-296.
76. Zhang H, Porro G, Orzech N et al. Am J Physiol Lung Cell Mol Physiol 2001: 280: L947-L954.
77. Deng A, Chen S, Li Q et al. J Immunol 2005: 174: 5243-5248.
78. Reinholz M, Ruzicka T, Schauber J. Ann Dermatol 2012: 24: 126-135.
79. Oppenheim J J, Tewary P, de la Rosa G et al. Adv Exp Med Biol 2007: 601: 185-194.
80. Zheng Y, Niyonsaba F, Ushio H et al. Br J Dermatol 2007: 157: 1124-1131.
81. Ross J I, Snelling A M, Carnegie E et al. Br J Dermatol 2003: 148: 467-478.
82. Tan H H. Am J Clin Dermatol 2004: 5: 79-84.
83. Hancock R E, Sahl H G. Nat Biotechnol 2006: 24: 1551-1557.
84. Peschel A, Sahl H G. Nat Rev Microbiol 2006: 4: 529-536.
85. Perron G G, Zasloff M, Bell G. Proc Biol Sci 2006: 273: 251-256.
86. Zhang L, Falla T J. Expert Opin Investig Drugs 2004: 13: 97-106.
87. Melo M N, Dugourd D, Castanho M A. Recent Pat Antiinfect Drug Discov 2006: 1: 201-207.
88. Wiesner J, Vilcinskas A. Virulence 2010: 1: 440-464.
89. Popovic S, Urban E, Lukic M et al. Peptides 2012: 34: 275-282.
90. Montalban-Lopez M, Sanchez-Hidalgo M, Valdivia E et al. Curr Pharm Biotechnol 2011: 12: 1205-1220.
91. Kang B S, Seo J G, Lee G S et al. J Microbiol 2009: 47: 101-109.
92. Bowe W P, Filip J C, DiRienzo J M et al. J Drugs Dermatol 2006: 5: 868-870.
93. Oh S, Kim S H, Ko Y et al. Food Chem Toxicol 2006: 44: 1184-1190.
94. Dombrowski Y, Peric M, Koglin S et al. Arch Dermatol Res 2010: 302: 401-408.
95. Reichrath J. Exp Dermatol 2007: 16: 618-625.
96. Allaker R P, Zihni C, Kapas S. FEMS Immunol Med Microbiol 1999: 23: 289-293.
97. Müller F B, Müller-Rover S, Korge B P et al. Br J Dermatol 2003: 148: 30-38.